Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapy.
about
Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.Commandeering a biological pathway using aptamer-derived molecular adaptorsExploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infectionThe non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.
P2860
Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapy.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Complement and cancer: activat ...... etical base for immunotherapy.
@en
Complement and cancer: activat ...... etical base for immunotherapy.
@nl
type
label
Complement and cancer: activat ...... etical base for immunotherapy.
@en
Complement and cancer: activat ...... etical base for immunotherapy.
@nl
prefLabel
Complement and cancer: activat ...... etical base for immunotherapy.
@en
Complement and cancer: activat ...... etical base for immunotherapy.
@nl
P1476
Complement and cancer: activat ...... retical base for immunotherapy
@en
P2093
P304
P577
1985-01-01T00:00:00Z